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                       Abstract


	
The thesis entitled “Studies Directed Towards the Total Synthesis of Ionomycin and Development of Novel Methodologies” has been divided into three chapters.
Chapter I: This chapter deals with introduction to Polyether Antibiotic, including some of potent antibiotic marine macrolide and the approaches cited in the literature towards the synthesis of Antibiotic Ionomycin, including the total synthesis.
Chapter II: This chapter describes the deals with present work of Ionomycin.
Chapter III: This chapter describes the development of novel methodologies, which is further subdivided into two sections.
Section A: This section describes LiClO4-catalyzed highly diastereoselective synthesis of cis-aziridine carboxylates. 
Section B: This section describes enzymatic resolution of N-aryl aziridine carboxylates.











 CHAPTER I: Introduction and previous approaches of Ionomycin.
Ionomycin, (Fig. 1) was first isolated from the fermentation broths of Streptomycin congoblatus1 in 1978. Ionomycin is distinct from the other members of the polyether antibiotic family in several important ways. Firstly, it is doubly charged, and therefore highly selective for divalent ions. This property is in direct contrast to the monobasic chelating effects of other polyether antibiotics and allows ionomycin to chelate divalent 
ions as adibasic acid in an octahedral coordination system, as a 1:1 charge-neutral complex.2 Calcimycin is the only other ionophore to similarly distinguish between 
monovalent and divalent cations, differentiating between calcium and magnesium as its 2:1 
Ligand/metal complex.3 a second anomaly is present in the P-dicarbonyl functionality at C9-C11, a rarity in natural products. 
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CHAPTER II: Stereospecific synthesis of C3-C10, C11-C16 and C17-C23 fragments of Ionomycin.
Retrosynthetic stategy of Ionomycin:The successful synthesis of a complex molecule depends upon the analysis of the problem to develop feasible scheme of synthesis generally consisting of a pathway of synthetic intermediates connected by possible reactions for the required interconversions. We chose to adopt a highly convergent strategy for the synthesis of Ionomycin disconnecting the carbon backbone at C (10-11) and C (16-17) E-alkenes thus dividing the target into three key subunits 2, 3 and 4.
	
Scheme 1


The advantages of making use of such a common bicyclic precursor 5 are manifold. The inherent rigidity of bicyclic intermediate 5 facilitates functionalisation in a stereo controlled fashion. The bicyclic compound 5 has five stereogenic centers and two prostereogenic sp2 sites, which could facilitate further functionalisation. 
Synthesis of common bicyclic precursor (6):
The initial attempts toward the synthesis of Ionomycin began with the synthesis of bicyclic precursor 6, which is common starting material for fragments C3-C10, C11-C16 and C17-C23. The bicyclic ketone 6 was prepared by employing the [3+4] cycloaddition of oxyallyl cation and furan 9 as reported by Hoffman and co-workers.4 The oxalyl cation, generated from 2,4-dibromopentanone 8 with Zn-Cu couple at –10 oC, when treated with furan undergo [3+4] cycloaddition to afford 6, 10 and 11 in the ratio 8:1:1. The stereo selective reduction of these ketones with DIBAL-H exclusively gave the corresponding endo alcohol 12 and two other isomers. 








Scheme 2

The required alcohol 12 was separated from the other isomers by column chromatographic technique and the structure was confirmed from spectral studies. The hydroxyl group of compound 12 was then protected as its benzyl ether 13 using NaH and benzyl bromide. Asymmetric hydro boration of olefin13 using (+)-diisopino camphenyl borane 5 proceeded smoothly to give the alcohol 14 with high enantiomeric purity in 96% yield. The alcohol 14 was converted to the lactone 5 by a two-step sequence, PCC oxidation of alcohol 14 followed by Baeyer-Villiger oxidation of the resulting ketone 15 (Scheme 3).
Scheme 3
Synthesis of C17-C23 fragment of Ionomycin (3):
 Acetylinic C17-C23 fragment of Ionomycin achieved in 9 steps from known bicyclic precursor, which was obtained from [4+2] cyclo addition of 2, 4 dibromo-3-pentanone and furan. The key feature of the strategy is the generation of 3-stereogenic centers from a single bicylic precursor, which has been utilized as a chiral building block for the synthesis of various natural products. 









Scheme 4
Having synthesized the bicyclic lactone 5 with all the functionalities for elaboration of the C3–C9 fragment, attention was directed to the opening of lactone ring. Accordingly lactone 5 on treatment with LAH in dry THF gave a polar compound in 80% yield, which was found to be the expected triol 16 (Scheme 4). The primary hydroxyl groups of compound 16 were selectively protected as TBDPS ether. Some more steps and the low yield of the expected product forced us to abandon this route. 
Since the Mitsunobu protocol for the inversion at C-5 centre failed it was decided to explore the oxidation reduction strategy.  Oxidation of compound 17 using Dess-Martin periodinane afforded the keto compound 18 in 95% yields. It was found that the reduction of keto compound 18 using NaBH4 in MeOH:THF (4:1) afforded the required -isomer 19 as the major product (19:17 = 9:1).










Scheme 5
The deprotection of TBDPS group of compound 19 with TBAF in THF afforded the triol 20 and the resultant triol 20 was protected as its monoacetonide 21 using dimethoxypropane and catalytic amount of PTSA in acetone as shown in scheme 5. The hydroxyl group in acetonide compound 21 was transformed into aldehyde 22 6 using o-iodoxybenzoic acid, DMSO in DCM at room temperature. The aldehyde 22 was transformed to acetylenic compound 2 7 by Corey-Fuchs protocol. The aldehyde 22 was transformed to dibromo compound 23 by treatment with CBr4, TPP and triethylamine in dry DCM (yield 85%) and When the dibromo compound 23 was treated with EtMgBr (in situ generated from EtBr and Mg in dry THF at 0 oC) gave the acetylene compound 2  in 75% yield. (Scheme 5)
Synthesis of C11-C16 fragment of Ionomycin (3):
Synthesis of C11-C16 fragment began using common by cyclic precursor that was utilized in first fragment synthesis. This fragment was achieved in 14 steps. The synthesis of C11-C16 fragment of Ionomycin began with known common bicyclic precursor, which was synthesized in Chapter I.  Alkylation at the -position of the lactone 5 was achieved by treating it with methyl iodide in the presence of LDA in dry THF at –78 0C to give a compound 25 in 85% yield (Scheme 6).

 Having synthesized the bicyclic lactone 24 with all the functionalities for elaboration of the C3 – C9 fragment, attention was directed to the opening of lactone ring. It was felt that reduction of lactone 24 would be the most ideal strategy. Accordingly lactone 24 on treatment with LAH in dry THF gave a polar compound in 80% yield, which was found to be the expected triol 25 (Scheme 6). The triol 25 was protected as its monoacetonide 26 using 2, 2-dimethoxy propane and catalytic amount of PPTS in DCM in 80% yield and the primary alcohol 26 was treated with 1.1 eq of TBDPSCl and 1.5 eq of imidazole in DCM afforded the protected compound 27 in 92% yield (Scheme 6)








Scheme 6
            Further goal at this stage was to knock out the OBn group from compound 27. In that consequence benzyl group of compound 27 as deprotected using Li in Naphthalene to give compound 28 8 in 78% yield and next we moved to knock out the 2o-hydroxygroup, which was done via. xanthate 29. Compound 28 reacted with CS2 in standard conditions 9 


to obtain xanthate 29, which was subjected to reductive elimination using Bu3SnH to give compound 30.10








Scheme 7
Compound 30 was treated with catalytic amount of PPTS in methanol to afford diol 31 and subsequent oxidation with 3.5 eq of IBX and DMSO in THF afforded diketo 32 (Scheme 7). The 1, 2-diketo group in compound 32 was reduction with sodium borohydride in methanol afforded 1, 2 diol 33 in 82 % yield (Scheme 7). Oxidative cleavage of compound 33with sodium periodate in THF-water (8:2) at room temperature afforded the aldehyde and the aldehyde 35 was converted to dithiane 35 through carbonyl protection by 1,3 propane dithiol under acidic condition according to Scheme 7. Thus, when aldehyde 34 was allowed to react with 1, 3-propane dithiol in the presence of catalytic amount of BF3.OEt211 in dry DCM afforded the dithiane 35 in yield 94%.

 

Next goal of the programme was to introduce iodo functionality at the primary hydroxyl group. Compound 35 was treated with TBAF to obtain compound 36 12 in 85 % yield and 
the iodination 13 of hydroxyl group of 36 using I2, TPP and imidazole in acetonitrile and diethyl ether mixture at room temperature afforded the iodo compound 37 in yield 85%, which is corresponding to C11-C16 fragment of Ionomycin.
Synthesis of C3-C10 fragment of Ionomycin
 Synthesis of C3-C10 fragment of Ionomycin began with diol 31, which was utilized in the synthesis of C11-C16 fragment of Ionomycin of using common bicyclic precursor that was utilized in first and second fragment. Synthesis of this fragment achieved in 15 steps.








Scheme 8
One of the two hydroxyl groups of 31 was protected as its mono benzyl ether using 1.1 eq NaH and BnBr in the presence of catalytic amount TBAI in dry THF at room temperature to furnish 37 in 90% yield. Next we moved to knock out the 2o-hydroxygroup, which was 

done via. xanthate 38. Compound 37 reacted with CS2 in standard conditions to obtain xanthate 38, which was subjected to reductive elimination using Bu3SnH to give compound 39 (Scheme 8). Compound 39 was treated with TBAF to obtain compound 40 
in 86 % yield. Compound 40 which on oxidation using IBX and DMSO in DCM afforded aldehyde 41 (Scheme 8). Further aldehyde 41 was exposure to Grignard reaction. The methylene alcohol could be easily obtained by reaction of aldehyde 41 with MeMgI in ether at room temperature in 89% yield and the compound 42 was oxidized with Des-Martin periodinane 14 to give methyl keto 4 in 88% yield, which is corresponding to the C3-C10 fragment of Ionomycin.
In conclusion, these stereospecific C3-C10, C11-C16 and C17-C23 fragments synthesis illustrates the dynamic utility of the common bicyclic precursor 5 and its desymmetrisation approach to fix nine required stereo centers. Thus we have demonstrated three key fragments of Ionomycin in very efficient manner.
CHAPTER III: Development of new methodologies. This chapter further divided into two sections.
Section A: LiClO4-catalyzed highly diastereoselective synthesis of cis-aziridine carboxylates 
Aziridines are useful building blocks for the synthesis of many biologically active compounds such as amino alcohols, unnatural amino acids and nitrogenous heterocycles.15 Aziridines are carbon electrophiles capable of reacting with various nucloephiles and their ability to undergo regioselective ring opening contributes to their synthetic value. The nucleophilic ring-opeing of aziridines leads to many biologically active compounds such as ,-unsaturated amino esters, -lactam antibiotics and alkaloids.16


In recent years, LiClO4 in diethyl ether (LPDE) has emerged as a mild Lewis acid imparting high regio-, chemo- and stereoselectivity in various organic transformations.17 
Lithium perchlorate is found to retain its activity even in the presence of amines and has also been found to activate effectively nitrogen-containing compounds such as imines.18



Scheme 9
In this part of work we explored the facile synthesis of highly diastereoselective cis-aziridine carboxylates by the reaction of aldimines generated in situ from aldehydes and amines in the presence of a catalytic amount of lithium perchlorate. Accordingly, treatment of benzaldehyde and aniline with ethyl diazoacetate in the presence of 10 mol% of lithium perchlorate gave the corresponding ethyl 1,3-diphenylaziridine-2-carboxylate (3a) in 87% yield with high cis-selectivity (Scheme 9). The cisstereochemistry of the aziridine 3a was confirmed by the large coupling constant (J=6.9 Hz) of the aziridine ring hydrogens at _ 3.20 and 3.59 (the ring protons of trans-3a appear at 3.20 and 3.80 with a smaller coupling constant, J=2.0–3.0 Hz).In summary, acetonitrile solutions of lithium perchlorate were found to be a highly efficient and convenient catalytic media for the synthesis of cis-aziridine carboxylates from aldehydes, amines and ethyl diazoacetate in a single-step operation. In addition to its simplicity and milder reaction conditions, this method provides high yields of products with high cis-selectivity which makes it a useful and attractive strategy for the preparation of cis-aziridine carboxylates of synthetic importance.
























Section B: Enzymatic resolution of N-arylaziridine carboxylates.
Candida rugosa lipase (CRL) is an extracellular protein, inexpensive and accepts a broad range of substrates. It is extensively used for the hydrolysis and esterification of organic compounds 19 and the knowledge 20 of its crystal structure has greatly contributed to understanding the mechanism of its selective recognition of substrates.21 In order to improve the chemo-, region- and diastereoselectivity of the enzyme, commercial CRL as well as conventional purifications, 22 have been subjected to several treatments that cause molecular or conformational changes. Structural analysis reveals that the catalytic traid is not exposed to the reaction medium, and the polypeptide lid, which covers the active site of the native enzyme, is displaced before the substrate approaches the active site.23 Scattered data indicate that the method of CRL purification and the reaction medium 24 strongly influence the activity and selectivity of lipase but systematic studies in this area are rare. 25
In this part of work we report the kinetic resolution of racemic N-arylaziridine-2- carboxylates via enantioselective hydrolysis by C. rugosa lipase (CRL).





Scheme 10


Hydrolysis was conducted in PH 7.5 phosphate buffer (0.1 M) and due to the low solubility of the substrates in buffer solution, dioxane was used as the co-solvent. The hydrolysis was terminated at around 45–50% conversion by extraction with EtOAc. The crude optically active esters obtained after evaporation of the solvent were flash chromatographed on silica gel (EtOAc/n-hexane gradient) to afford pure N-arylaziridine carboxylates. The enantiomeric purity was determined by chiral HPLC and 1H NMR-shift reagent methods. Moderate to high enantiomeric purity (70–99%) was observed among the substrates (see Table 1) studied. The absolute configuration of all the unhydrolyzed N-arylaziridine carboxylates was determined as S by comparing the sign of the specific rotation, based on a literature precedent.
We have successfully demonstrated herein, the kinetic resolution of synthetically important N-arylaziridine-2- carboxylates in moderate to high enantiomeric purity using Candida rugosa lipase. All the unhydrolyzed esters were found to be of an (S)-configuration. (Scheme 10)










Table 1. Enantioselective hydrolysis of aziridine-2-carboxylates by C. rugosa














a E/S refers to enzyme, substrate (wt/wt) ratio.
b + or - refers to the sign of the specific rotation.
 c Determined by chiral HPLC conditions: Chiracel ODTM, Daicel, Japan; 5  250mm,  330 nm; 10% isopropanol in hexane; .flow rate 0.6 mL/min and
by 1H NMR with Eu(hfc)3 in CDCl3.
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